KALA BIO, Inc. (KALA) › Shareholders' EquityKALA BIO, Inc. (KALA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: -$40.72M2015: -$56.66M2016: -$87.76M2017: $89.68M2018: $104.98M2019: $29.69M2020: $100.00M2021: $16.80M2022: $18.97M2023: $7.50M2024: $12.33M2025: $7.00M$7.00M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$7.00M-43.3%2024$12.33M+64.3%2023$7.50M-60.5%2022$18.97M+12.9%2021$16.80M-83.2%2020$100.00M+236.8%2019$29.69M-71.7%2018$104.98M+17.1%2017$89.68M+202.2%2016-$87.76M-54.9%2015-$56.66M-39.1%2014-$40.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share